ByteDance spins off AI drug discovery unit, seeks independent financing

The company plans to keep control of the new business as Liu Kai’s 50-person team transfers core algorithms, platforms and early pipeline assets.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.